Close Menu

NEW YORK – The US Department of Justice said yesterday that UTC Laboratories, previously known as Renaissance Rx, has agreed to pay $41.6 million to settle allegations that they paid kickbacks for lab referrals for pharmacogenetic testing and for billing for tests that were not medically necessary.

The company also accepted a 25-year ban on participating in any federal healthcare program.

Additionally, company principals Tarun Jolly, Patrick Ridgeway, and Barry Griffith agreed to pay $1 million to resolve the allegations.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.